External support in preventing vein graft failure

Asian Cardiovascular and Thoracic Annals

Volumn 20, Issue 5, 2012, Pages 615-622

  Hu, Jia ^a   Wan, Song ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherosclerosis; Blood vessel prosthesis; Coronary artery bypass; Neointima; Saphenous vein

Indexed keywords

5 HYDROXYTRYPTOPHAN; DACRON; ENDOTHELIN 1; NITINOL; NORADRENALIN; POLITEF; POLYESTER; POLYETHYLENE; POLYGLACTIN; POLYPROPYLENE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SOMATOMEDIN C; SUPEROXIDE;

ANGIOGENESIS; ARTERIAL CIRCULATION; ATHEROGENESIS; BIODEGRADABILITY; BLOOD VESSEL PROSTHESIS; CELL MIGRATION; CORONARY ARTERY BYPASS GRAFT; DACRON IMPLANT; DEGRADATION KINETICS; DISEASE COURSE; EXTERNAL VASCULAR STENT; FOREIGN BODY REACTION; GRAFT FAILURE; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HEMODYNAMICS; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; NEOINTIMA; NONHUMAN; PULSATILE FLOW; REINNERVATION; REVIEW; SAPHENOUS VEIN GRAFT; SHEAR STRESS; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE; VASCULAR STENT; VEIN WALL; WALL STRESS; ANIMAL; BIOMECHANICS; GRAFT OCCLUSION; HYPERPLASIA; PATHOLOGY; PATHOPHYSIOLOGY; PROSTHESIS; SAPHENOUS VEIN; STENT; TRANSPLANTATION; TREATMENT FAILURE; VASCULAR PATENCY;

ANIMALS; BIOMECHANICS; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; NEOINTIMA; PROSTHESIS DESIGN; SAPHENOUS VEIN; STENTS; TREATMENT FAILURE; VASCULAR PATENCY;

EID: 84875859285     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492312456980     Document Type: Review

References (39)

1. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 32: 2125-2134.
2. Wan S, George SJ, Berry C and Baker AH. Vein graft failure: current clinical practice and potential for gene therapeutics. Gene Ther 2012; 19: 630-636.
3. Ng CS and Wan S. Limiting inflammatory response to cardiopulmonary bypass: pharmaceutical strategies. Curr Opin Pharmacol 2012; 12: 155-159.
4. George SJ, Wan S, Hu J, Johnson JL, MacDonald R and Baker AH. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 2011; 124: S135-S142.
5. Kang N, Ng CS, Hu J, Qiu ZB, Underwood MJ, Jeremy JY and Wan S. Role of osteopontin in the development of neointimal hyperplasia in vein grafts. Eur J Cardiothorac Surg 2012; 41: 1384-1389.
6. Mehta D, George SJ, Jeremy JY, Izzat MB, Southgate KM, Bryan AJ, et al. External stenting reduces long-term medial and intimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nat Med 1998; 4: 235-239.
7. Jeremy JY, Gadsdon P, Shukla N, Vijayan V, Wyatt M, Newby AC, et al. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials 2007; 28: 895-908.
8. Desai M, Mirzay-Razzaz J, von Delft D, Sarkar S, Hamilton G and Seifalian AM. Inhibition of intimal formation and hyperplasia in vein grafts by external stent/ sheath. Vasc Med 2010; 15: 287-297.
9. Murphy GJ, Newby AC, Jeremy JY, Baumbach A and Angelini GD. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J Thorac Cardiovasc Surg 2007; 134: 504-505.
10. Schoettler J, Jussli-Melchers J, Grothusen C, Stracke L, Schoeneich F, Stohn S, et al. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact Cardiovasc Thorac Surg 2011; 13: 396-400.
11. Parsonnet V, Lari AA and Shah IH. New stent for support of veins in arterial grafts. Arch Surg 1963; 87: 696-702.
12. Barra JA, Volant A, Leroy JP, Braesco J, Airiau J, Boschat J, et al. Constrictive perivenous mesh prosthesis for preservation of vein integrity. Experimental results and application for coronary bypass grafting. J Thorac Cardiovasc Surg 1986; 92: 330-336.
13. Owens CD. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg 2010; 51: 736-746.
14. Cheng J, Wang Y, Ma Y, Chan BT, Yang M, Liang A, et al. The mechanical stress-activated serum-, glucocorticoid- regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010; 107: 1265-1274.
15. El-Kurdi MS, Hong Y, Stankus JJ, Soletti L, Wagner WR and Vorp DA. Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap. Biomaterials 2008; 29: 3212-3220.
16. Zilla P, Human P, Wolf M, Lichtenberg W, Rafiee N, Bezuidenhout D, et al. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates. J Thorac Cardiovasc Surg 2008; 136: 717-725.
17. Human P, Franz T, Scherman J, Moodley L and Zilla P. Dimensional analysis of human saphenous vein grafts: Implications for external mesh support. J Thorac Cardiovasc Surg 2009; 137: 1101-1108.
18. Zilla P, Wolf M, Rafiee N, Moodley L, Bezuidenhout D, Black M, et al. Utilization of shape memory in external vein-graft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: a nonhuman primate study. J Vasc Surg 2009; 49: 1532-1542.
19. Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC, et al. A long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg 2004; 40: 1011-1019.
20. George SJ, Izzat MB, Gadsdon P, Johnson JL, Yim AP, Wan S, et al. Macro-porosity is necessary for the reduction of intimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis 2001; 155: 329-336.
21. Jeremy JY, Bulbulia R, Johnson JL, Gadsdon P, Vijayan V, Shukla N, et al. A bioabsorbable (polyglactin) external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg 2004; 127: 1766-1772.
22. Jeremy JY, Dashwood MR, Mehta D, Izzat MB, Shukla N and Angelini GD. Nitric oxide, prostacyclin and cyclic nucleotide formation in externally stented porcine vein grafts. Atherosclerosis 1998; 141: 297-305.
23. Angelini GD, Lloyd C, Bush R, Johnson J and Newby AC. An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs. J Thorac Cardiovasc Surg 2002; 124: 950-956.
24. Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, et al. Inhibition of accelerated atherosclerosis in vein grafts by placement of an external stent in ApoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 2002; 22: 1433-1438.
25. Dashwood MR, Gibbins R, Mehta D, Bashar Izzat M, Angelini GD and Jeremy JY. Neural reorganisation in porcine vein grafts: a potential role for endothelin-1. Atherosclerosis 2000; 150: 43-53.
26. Dashwood MR and Loesch A. The saphenous vein as a bypass conduit: the potential role of vascular nerves in graft performance [Review]. Curr Vasc Pharmacol 2009; 7: 47-57.
27. Dashwood MR, Angelini GD, Wan S, Yim A, Mehta D, Izzat MB, et al. Does external stenting reduce porcine vein-graft occlusion via an action on vascular nerves? J Card Surg 2002; 17: 556-560.
28. Zurbrügg HR and Hetzer R. The use of biocompoundgrafts together with varicose veins. First clinical experience. J Cardiovasc Surg 1996; 37: 143-146.
29. Zurbrügg HR, Knollmann F, Musci M, Wied M, Bauer M, Chavez T, et al. The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency. Ann Thorac Surg 2000; 70: 1536-1540.
30. Rescigno G, Angelini A, D'Alfonso A and Torracca L. Coronary graft use of a new external mesh support. Interact Cardiovasc Thorac Surg 2010; 10: 645-647.
31. Izzat MB, Mehta D, Bryan AJ, Reeves B, Newby AC and Angelini GD. Influence of external stent size on early medial and intimal thickening in a pig model of saphenous vein bypass grafting. Circulation 1996; 94: 1741-1745.
32. You Q, Duan L, Wang F, Du X and Xiao M. Characterization of the inhibition of vein graft intimal hyperplasia by a biodegradable vascular stent. Cell Biochem Biophys 2011; 59: 99-107.
33. Franz T, Human P, Dobner S, Reddy BD, Black M, Ilsley H, et al. Tailored sizes of constrictive external vein meshes for coronary artery bypass surgery. Biomaterials 2010; 31: 9301-9309.
34. Zilla P, Moodley L, Wolf MF, Bezuidenhout D, Sirry MS, Rafiee N, et al. Knitted nitinol represents a new generation of constrictive external vein graft meshes. J Vasc Surg 2011; 54: 1439-1450.
35. van der Merwe H, Daya Reddy B, Zilla P, BezuidenhoutD and Franz T. A computational study of knitted Nitinol meshes for their prospective use as external vein reinforcement. J Biomech 2008; 41: 1302-1309.
36. Liao SW, Lu X, Putnam AJ and Kassab GS. A novel time-varying poly lactic-coglycolic acid external sheath for vein grafts designed under physiological loading. Tissue Eng 2007; 13: 2855-2862.
37. Skalsky I, Filova E, Szarszoi O, Parizek M, Lytvynets A, Maluskova J, et al. A periadventitial sirolimus-releasing mesh decreased intimal hyperplasia in a rabbit model. Physiol Res 2011; 60: 585-588.
38. Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinck E, Yla-Herttuala S, et al. Angiogenesisdependent and independent phases of intimal hyperplasia. Circulation 2004; 110: 2436-2443.
39. Wan S, Arifi AA, Chan MC, Yip JH, Ng CS, Chow LT, et al. Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts. Eur J Cardiothorac Surg 2006; 29: 742-746.